Dehydrated Curry Leaves

About

What it is and where it shows up.

Dehydrated curry leaves are the dried or powdered leaves of Murraya koenigii (Family Rutaceae), a tropical and subtropical plant widely used in South and Southeast Asian cuisines. They are used as a flavouring and seasoning ingredient and have a long history of use in Ayurvedic medicine for their antioxidant, antidiabetic, and anti-inflammatory properties.

Safety summary

The regulatory and scientific consensus.

Dehydrated curry leaves are well-tolerated by the general adult population with no established ADI and no known bans or significant regulatory restrictions at culinary doses. Contaminant standards (e.g., permitted additives on a dry matter basis) apply under FSSAI regulations for dried herbs and spices. High-dose supplemental use (as extracts or concentrates) may interact with antidiabetic medications due to demonstrated hypoglycaemic effects in animal models.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
FSSAI (Food Safety and Standards Authority of India) (India)	Restricted	Dehydrated herbs, spices, and curry powder/masalas are subject to contaminant limits (e.g., permitted additives at up to 10 mg/kg on dry matter basis) under FSS Contaminants, Toxins and Residues Regulations, Version VI (2022). No banned-substance concern; this is a quality/safety contaminant control measure.source
FDA (Food and Drug Administration) (United States)	Approved	Curry leaves are not listed as a prohibited substance and are used as a spice/flavouring with a long history of common use in food before 1958, qualifying for GRAS status under 21 CFR 170.30(c) based on experience. No specific GRAS notice or food additive petition found for dehydrated curry leaves; regulated as a conventional spice.source

Who should approach with care

Whose guidance would steer them away.

Diabetes — Animal and human studies demonstrate dose-dependent hypoglycaemic and antihyperglycaemic effects of Murraya koenigii; at high supplemental doses, curry leaf extracts may potentiate antidiabetic drugs, risking hypoglycaemia.

Pregnancy — Certain carbazole alkaloids and bioactive compounds identified in Murraya koenigii have shown pharmacological activity in animal models; concentrated supplemental or extract forms should be used with caution during pregnancy until further human safety data are available.

Liver Disease — While polyphenol-rich extracts have shown hepatoprotective effects in animal studies, very high-dose supplemental use of concentrated curry leaf extracts has not been adequately assessed in patients with pre-existing liver disease.

Research citations

The sources behind this verdict.

1PubMed. Hypoglycemic and antihyperglycemic activity of Murraya koenigii leaves in diabetic rats. pubmed.ncbi.nlm.nih.gov
2FSSAI. Standards List of Standards – Dry Curry Leaves Powder, Spices and Condiments, 2023. fssai.gov.in
3FSSAI. Food Safety and Standards (Contaminants, Toxins and Residues) Regulations – Version VI, 2022. fssai.gov.in
4PubMed. Nutritive Importance and Therapeutics Uses of Three Different Varieties (Murraya koenigii, Micromelum minutum, and Clausena indica) of Curry Leaves: An Updated Review, 2021. pmc.ncbi.nlm.nih.gov
5PubMed. Evaluation of Bioactive Compounds, Pharmaceutical Quality, and Anticancer Activity of Curry Leaf (Murraya koenigii L.), 2014. pubmed.ncbi.nlm.nih.gov

Independently researched5 citations